Senate panel: Pharmally, gov’t execs in ‘grand conspiracy’

MANILA, Philippines, October 20 ------ President Rodrigo Duterte is at the center of a “grand conspiracy” to defraud the government of billions of pesos perpetrated at the height of the pandemic by his Chinese friend and former economic adviser Michael Yang, executives of Pharmally Pharmaceutical Corp. and former and current budget procurement officers, according to a report by the Senate blue ribbon committee released on Tuesday.

It was the President “who allowed his friends to bleed this nation’s coffers dry,” said Sen. Richard Gordon, who disclosed his committee’s preliminary report during Tuesday’s hearing, the 12th since the inquiry started on Aug. 18. “It is clear and categorical to us that this grand conspiracy could never have happened without the imprimatur of the President,” said the senator, who has been the target of many tirades from Duterte since the investigation started.

He said criminal charges should be filed against Yang, who allegedly provided financial backing for Pharmally, a company capitalized at only P625,000, so that it could fulfill its contracts amounting to P11.5 billion in 2020 and 2021 to supply the government with, among others, face masks and shields, personal protective equipment (PPE) and COVID-19 test kits. Gordon said the deals with the Procurement Service of the Department of Budget and Management (PS-DBM) and the Department of Health (DOH) were “were grossly and manifestly disadvantageous to the government.”

‘Special audit’

Presidential spokesperson Harry Roque dismissed the allegations against Duterte as a “tall tale.” “I will repeat, first of all, there was no overprice in the purchase of the PPEs according to the chairman of the Commission on Audit (COA),” Roque said in a press briefing. He also insisted that no law was violated in awarding the contracts to Pharmally because the Bayanihan 1 law authorized the President to make emergency purchases amid the pandemic. “If there was no violation of the law and no overprice, why will there be a grand conspiracy? That is a tall tale from a person who is politicking,” he said, referring to Gordon, who is running for reelection.

In separate hearings held by the House of Representatives and the Senate, COA Chair Michael Aguinaldo told lawmakers that its report contained no statements on overpricing. Aguinaldo did not say there was overprice but neither did he say that there was no overprice because COA’s “observation,” the audit body’s term for its comments, was “related more to inventory management” rather than prices of procured goods. He told the Senate that there would now be a “special audit” to look into it.

Gordon’s committee said Yang, a businessman, should be deported. But under Philippine law, such a move is usually made once all charges against a foreigner are resolved. The committee said Yang was liable specifically for perjury, violations of the Bayanihan 1 law and the Anti-Graft and Corrupt Practices Act “for causing undue injury” to the government by giving a private party unwarranted benefits, and entering into contracts which were “manifestly and grossly disadvantageous to the government.” Yang, who was defended by the President on several occasions, had denied that he gave Pharmally a loan so it could pay Chinese companies for the pandemic supplies.

Last year, the DOH transferred at least P42 billion of its pandemic funds to the PS-DBM to procure items that it found hard to purchase on its own. But the COA flagged the transfer for lack of a memorandum of agreement or other supporting documents.

“Our inquiry in aid of legislation reveals unconscionable, unabashed and unethical circumventions of our republican way of governance,” Gordon said. “We found that those involved prioritized their profits, commissions or kickbacks, instead of coming up with the right way to quell the pandemic,” he said. The Senate discovered that the PS-DBM awarded Pharmally the lion’s share of the contracts totaling P8.7 billion just for 2020 despite being undercapitalized. “From our investigation, it was clear that there were ‘unwarranted benefits, advantage or preference or favoritism’ for Pharmally, which only had a capital of P625,000, no experience in contracting, and even declared a loss in its first year of business. But it secured a whopping P8 billion to P11 billion in contracts from PS-DBM,” Gordon said.

Source: sports.inquirer.net